CPT1A and breast cancer: Compared to vehicle treatment, treatment with SP600125 significantly reduced the CPT1 activity and FAO rate in MCF7 and T47D cells (Fig. 6a, b), which demonstrated that JNK-mediated c-Jun phosphorylation modulated the activity of FAO in ER-positive BC cells.